dc.contributor.author
Langlitz, Nicolas
dc.contributor.author
Dyck, Erika
dc.contributor.author
Scheidegger, Milan
dc.contributor.author
Repantis, Dimitris
dc.date.accessioned
2021-10-04T14:56:25Z
dc.date.available
2021-10-04T14:56:25Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/32177
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-31905
dc.description.abstract
The revival of psychedelic research coincided and more recently conjoined with psychopharmacological research on how drugs affect moral judgments and behaviors. This article makes the case for a moral psychopharmacology of psychedelics that examines whether psychedelics serve as non-specific amplifiers that enable subjects to (re-)connect with their values, or whether they promote specific moral-political orientations such as liberal and anti-authoritarian views, as recent psychopharmacological studies suggest. This question gains urgency from the fact that the return of psychedelics from counterculture and underground laboratories to mainstream science and society has been accompanied by a diversification of their users and uses. We propose bringing the pharmacological and neuroscientific literature into a conversation with historical and anthropological scholarship documenting the full spectrum of moral and political views associated with the uses of psychedelics. This paper sheds new light on the cultural plasticity of drug action and has implications for the design of psychedelic pharmacopsychotherapies. It also raises the question of whether other classes of psychoactive drugs have an equally rich moral and political life.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
psychedelics
en
dc.subject
hallucinogens
en
dc.subject
morality and values
en
dc.subject
extrapharmacological variables
en
dc.subject
anthropology
en
dc.subject
psychotherapy
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
680064
dcterms.bibliographicCitation.doi
10.3389/fpsyt.2021.680064
dcterms.bibliographicCitation.journaltitle
Frontiers in Psychiatry
dcterms.bibliographicCitation.originalpublishername
Frontiers Media SA
dcterms.bibliographicCitation.volume
12
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
34408677
dcterms.isPartOf.eissn
1664-0640